The beneficial effects of native FGF21 and FGF21 analogues in normalizing glucose and lipid homeostasis have been demonstrated in a variety of preclinical metabolic disease models, including DIO mice, ob/ob mice, db/db mice, diabetic NHP and obese NHP [4–8]. Here, FGF21 is linked to Other metabolic disease.